Live Online Cardiology CME Presented by Johns Hopkins Kicks-Off Today, Wednesday July 27 at 10:00 AM EDT
Login to Watch Respected Cardiologists and Endocrinologists Present Topics in Acute Coronary Syndrome, Heart Failure and Diabetes at www.CardioCareLive.com
Activity Director Chris Cannon, MD to Comment on Use of Blood Thinners in Patients with ACS
Thousands of healthcare professionals are expected to login to watch ten interactive Continuing Medical Education (CME) sessions in three tracks covering topics in Acute Coronary Syndrome, Heart Failure and Diabetes. These educational summits are presented by the Johns Hopkins University School of Medicine. Live streaming video programming featuring some of the nation’s leading medical experts begins at 10:00 AM EDT on Wednesday, July 27th and again at 11:00 AM EDT on Thursday, July 28th, with individual presentations beginning on the hour. Login today and tomorrow at CardioCareLive, the world’s largest online cardiology congress.
The Acute Coronary Syndrome Education Summit, “How Do We Optimize Patient Outcomes with Antiplatelet and Anticoagulant Therapies?” is supported by educational grants from Daiichi/Lilly and The Medicines Co.; the Heart Failure Education Summit, “Evaluating Progress in Heart Failure,” is supported by educational grants from Boston Scientific, GE Healthcare and Thoratec, and the Diabetes Education Summit, “Diabetes Today: Individualized Approaches to Effective Management,” is supported by educational grants from Novo Nordisk and Lilly USA.
For time-constrained physicians and other healthcare practitioners, Johns Hopkins offers an easy and effective way to stay current on advances in cardiovascular care from the convenience of any computer. A total of 9.5 AMA PRA Category I Credits™ will be available during the live programming July 27th and July 28th, in addition to the 25 AMA PRA Category I Credits™ available on demand in enduring format at CardioCareLive. There is no charge to register and watch any educational session at CardioCareLive.
Practitioners who attend live may take advantage of interactive capabilities by texting in questions to be addressed live online by presenting faculty such as Activity Directors Roger Blumenthal, MD of Johns Hopkins University School of Medicine, and Christopher P. Cannon, MD, of Brigham & Women’s Hospital and Harvard Medical School, as well as faculty members Deepak Bhatt, MD, of VA Boston Healthcare System, Richard Nesto, MD of Lahey Clinic and Clyde Yancy, MD of Northwestern University Feinberg School of Medicine. Activity Director Chris Cannon, MD is expected to comment on the use of blood thinners such as Ticagrelor which gained FDA approval on July 20th as a treatment to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS) in his opening remarks for the Acute Coronary Syndrome Education Summit.
The live programs over two days feature the following educational topics:
Acute Coronary Syndrome Education Summit:
How Do We Optimize Patient Outcomes with Antiplatelet and Anticoagulant Therapies?
- Contemporary Anticoagulation Strategies in Patients With ACS
- Individualizing Antiplatelet and Anticoagulant Therapies in ACS Patients
- Challenges in Predicting the Risk of an Acute Thrombotic Event
- Antiplatelet Treatment: Applying the Guidelines and Incorporating New Therapies in UA and NSTEMI Practice
Heart Failure Education Summit: Evaluating Progress in Heart Failure
- Heart Failure: Where Are We Now, Where Are We Going?
- Management of Heart Failure with Device Therapies and Surgery
Diabetes Education Summit: Diabetes Today: Individualized Approaches to Effective Management
- Current Diabetes Management: State of the Art
- New and Emerging Therapies for Diabetes: Molecules, Mechanisms and Recent Clinical Evidence
- Treating Diabetes in Older Patients: Challenges and Strategies
- Case Studies in Diabetes: Optimizing Management for a Diverse Range of Patients
To learn more about supporting these and other Johns Hopkins educational programs at CardioCareLive, please contact info@CardioCareLive.com.
ABOUT CARDIOCARELIVE
CardioCareLive, the world’s largest cardiology congress, is presented by the Johns Hopkins University School of Medicine and produced by PlatformQ and takes place entirely online. CardioCareLive enables cardiologists, internal medicine specialists, family care physicians and other healthcare practitioners interested in understanding and managing patients with cardiovascular disease to learn, connect and interact in real time. Johns Hopkins University offers Continuing Medical Education (CME) at no cost at CardioCareLive, which delivers all the benefits of a physical conference, with live keynote presentations, lectures, real-time interactive Q&A and an exhibit floor, all from the convenience of a computer.
CardioCareLive and PlatformQ are trademarks of PlatformQ, LLC. All other trademarks or service marks are property of their respective owners.
ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS
ACUTE CORONARY SYNDROME
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HEART FAILURE
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DIABETES
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™from organizations accredited by the ACCME. Physician assistants may receive a maximum of 12 hours of Category 1 credit for completing these programs.
DATE OF RELEASE
Live sessions will be available July 27, 2011 from 9:00 AM – 7:00 PM (EDT) and July 28, 2011 from 11:00 AM-4:00 PM (EDT). ACS and Diabetes will be on-demand from July 28, 2011 to January 28, 2012 at www.CardioCareLive.com
LEARNING OBJECTIVES
After participating in this activity, the participant will demonstrate the ability to:
ACUTE CORONARY SYNDROME
•Properly apply anticoagulant therapies in patients with ACS; evaluate current research on new anticoagulant strategies.
•Apply guidelines’ recommendations on antiplatelet therapies in patients with unstable angina and non-STEMI ACS.
•Assess data on novel antiplatelet agents.
•Evaluate the risk of bleeding in patients with ACS.
•Assess the prognostic value of various ACS risk stratification schemes and biomarkers; select strategies, including combined approaches, to improve outcomes’ prognosis.
HEART FAILURE
•Discuss the use of biomarkers to guide management of heart failure.
•Evaluate recommendations of the updated guidelines on medical management of heart failure.
•Assess the use of device therapies for heart failure patients and progress in this area.
•Identify patients who could benefit from mechanical circulatory support.
•Evaluate the potential for recent research on myocyte biology to transform disease management in patients with heart failure.
•Review current tests used to assess heart failure risk and prognosis, including imaging studies and application of biomarkers.
•Identify new approaches to treatment of patients with heart failure using pharmacotherapy.
•Identify the impact of co-morbidities in patients with heart failure.
DIABETES
•Assess current evidence-based guidelines for diabetes management and make practice modifications that improve glycemic control as well as control of cardiovascular risk factors in diabetes patients.
•Evaluate clinical trial results on current and emerging antiglycemic therapies and make appropriate, individualized choices for diabetes patients with differing clinical characteristics.
•Institute effective management strategies for diabetes patients who are older and/or who have multiple co-morbidities.
•Develop evidence-based, long term management plans for diabetes patients that take into account patient characteristics including age, co-morbidities, length of time with the disease, self management abilities, and other important factors that may influence success in realizing glycemic goals.
TARGET AUDIENCE
Cardiologists, interventional cardiologists, cardio-thoracic surgeons, endocrinologists, geriatricians, intensive care medicine specialists and internal medicine practitioners. Secondary audiences will include primary care physicians, family physicians, physician assistants, diabetologists and diabetes educators, nurses and advanced practice nurses, and pharmacists.
FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES
It is the policy of the Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the course handout materials.
Press@CardioCareLive.com
617.938.6008
http://platformq.com/
Tags: